DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2021/049853, filed Sep 10, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,981,940 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,188,061 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,188,062 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,398,384 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | ||
| Application 18/946,402 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same Pending Not granted | Life Edit Therapeutics, Inc. | Pending | Not granted | ||
| Application 18/955,480 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same Pending Not granted | Life Edit Therapeutics, Inc. | Pending | Not granted | ||
| Application 19/055,281 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use Pending Not granted | Life Edit Therapeutics, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Lifeedit, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.